Completion of patient recruitment in the CoolCryo® clinical trial

October 30, 2025

Medinice S.A. has completed patient recruitment for the ongoing CoolCryo® clinical trial, conducted at the Silesian Center for Heart Diseases in Zabrze and University Hospital named after Dr. A. Jurasz in Bydgoszcz.

Achieving full enrollment marks the completion of a key milestone in the project. Following a six-month follow-up and data analysis, the company will proceed with CE MDR certification which will facilitate commercialization in the European market.

CoolCryo® is an innovative cardiac cryoablation technology using liquid nitrogen to treat heart rhythm disorders.